Arcadia Biosciences stock stays below Nasdaq's USD 1 threshold

Published on 10/06/2026 at 14:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Arcadia Biosciences stock was last at USD 0.29 on October 5, 2026, down 0.52 percent. Q2 revenue was USD 1.443 million and net loss was USD 6.266 million.

RKDA, US0390143032, Illustration mit AI erstellt.

Arcadia Biosciences (ISIN US0390143032) was last at USD 0.29 on Nasdaq on October 5, 2026 at 4:00 p.m. ET, leaving the stock below the USD 1.00 minimum bid-price requirement. The immediate company issue is a Nasdaq compliance plan due October 15, 2026, according to StockTitan.

Nasdaq equity test sets October 15 deadline

Arcadia reported stockholders' equity of USD 633,000 as of June 30, 2026, compared with Nasdaq's continued-listing threshold of USD 2.5 million. The gap is USD 1.867 million, making the compliance filing the central near-term corporate date for RKDA.

StockTitan reports that the common stock continues trading on Nasdaq while the company prepares its plan. The separate bid-price deficiency carries an initial compliance period ending February 1, 2027, with a requirement of at least USD 1.00 for ten consecutive business days.

Q2 revenue reached USD 1.443 million

Arcadia's Q2 2026 revenue was USD 1.443 million, up from USD 1.100 million in Q1 2026. The company posted a net loss attributable to common stockholders of USD 6.266 million, compared with a USD 4.385 million loss in Q1, according to StockTitan.

Cash and cash equivalents stood at USD 4.178 million on June 30, 2026, while operating cash use was USD 319,000 in Q2. The combination of a USD 6.266 million quarterly loss and USD 633,000 of equity explains why the listing issue matters beyond the share-price threshold.

Reverse split gives the board another option

At the September 10, 2026 annual meeting, shareholders authorized a reverse stock split between 1-for-2 and 1-for-10 before June 30, 2027. TipRanks reported that the measure could support compliance efforts, but the authorization itself does not restore Nasdaq compliance.

RKDA remains far below the bid threshold

RKDA's October 5 price of USD 0.29 was USD 0.71 below the Nasdaq bid-price requirement, while the 52-week range was USD 0.22 to USD 6.71. Market capitalization was USD 0.4 million and trading volume reached 150,629 shares on the quoted session.